Moderna Inc. buy The Goldman Sachs Group, Inc.
Start price
16.09.24
/
50%
€62.58
Target price
16.09.25
€124.93
Performance (%)
-66.01%
End price
17.09.25
€21.27
Summary
This prediction ended on 17.09.25 with a price of €21.27. The BUY prediction by The_Goldman_Sachs_Gr for Moderna Inc. performed very badly with a performance of -66.01%. The_Goldman_Sachs_Gr has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 4.774% | 4.774% | -33.132% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $178.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten